Kyla’s main research interests are around examining the effectiveness, cost effectiveness and safety of smoking cessation medicines, particularly varenicline (and e-cigarettes) and the development of complex interventions to prevent and reduce opioid painkiller dependence in patients with chronic non cancer pain.